Recent publications on Cancer

Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Blasi PR. Screening for skin cancer in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA.2016;316(4):436-447. doi:10.1001/jama.2016.5415. PubMed

Thielke S, Shortreed SM, Saunders K, Turner JA, LeResche L, von Korff M. A prospective study of predictors of long-term opioid use among patients with chronic non-cancer pain.  Clin J Pain. 2016 Jul 15. [Epub ahead of print]. PubMed

Chang OH, Liu F, Knopp E, Muehlenbachs A, Cope JR, Ali I, Thompson R, George E. Centrofacial balamuthiasis: case report of a rare cutaneous amebic infection. Cutan Pathol. 2016 Oct;43(10):892-7. doi: 10.1111/cup.12748. Epub 2016 Jul 12. PubMed

Lin JS, Piper MA, Perdue LA, Rutter CM, Webber EM, O'Connor E, Smith N, Whitlock EP. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016 Jun 21;315(23):2576-94. doi: 10.1001/jama.2016.3332. Review. PubMed

Klabunde CN, Zheng Y, Quinn VP, Beaber EF, Rutter CM, Halm EA, Chubak J, Doubeni CA, Haas JS, Kamineni R, Schapira MM, Vacek PM, Garcia MP, Corley DA on behalf of PROSPR consortium. Influence of age and comorbidity on colorectal cancer screening in the elderly. Am J Prev Med. 2016 Sep;51(3):e67-75. doi: 10.1016/j.amepre.2016.04.018. Epub 2016 Jun 22. PubMed

Knudsen AB, Zauber AG, Rutter CM, Naber SK, Doria-Rose VP, Pabiniak C, Johanson C, Fischer SE, Lansdorp-Vogelaar I, Kuntz KM. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force. JAMA. 2016 Jun 15. doi: 10.1001/jama.2016.6828. [Epub ahead of print]. PubMed

Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, Garcia FA, Gillman MW, Harper DM, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Owens DK, Phillips WR, Phipps MG, Pignone MP, Siu AL. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016 Jun 15. doi: 10.1001/jama.2016.5989. [Epub ahead of print]. PubMed

Nekhlyudov L, Walker R, Ziebell R, Rabin B, Nutt S, Chubak J. Cancer survivors' experiences with insurance, finances, and employment: results from a multisite study.  J Cancer Surviv. 2016 Jun 9. [Epub ahead of print]. PubMed

Halm EA, Beaber EF, McLerran D, Chubak J, Corley DA, Rutter CM, Doubeni CA, Haas JS, Balasubramanian BA. Association between primary care visits and colorectal cancer screening outcomes in the era of population health outreach.  J Gen Intern Med. 2016 Oct;31(10):1190-7. doi: 10.1007/s11606-016-3760-9. Epub 2016 Jun 8. PubMed

Lowery JT, Ahnen DJ, Schroy PC 3rd, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the-science review. Cancer. 2016 Jun 3. doi: 10.1002/cncr.30080. [Epub ahead of print]. PubMed

Calip GS, Yu O, Elmore JG, Boudreau DM. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.  Cancer Causes Control. 2016;27(5):709-20. doi: 10.1007/s10552-016-0744-3. Epub 2016 Apr 6.  PubMed

McCarthy AM, Kim JJ, Beaber EF, Zheng Y, Burnett-Hartman A, Chubak J, Ghai NR, McLerran D, Breen N, Conant EF, Geller BM, Green BB, Klabunde CN, Inrig S, Skinner CS, Quinn VP, Haas JS, Schnall M, Rutter CM, Barlow WE, Corley DA, Armstrong K, Doubeni CA. Follow-up of abnormal breast and colorectal cancer screening by race/ethnicity. Am J Prev Med. 2016 Apr 28. pii: S0749-3797(16)30075-7. doi: 10.1016/j.amepre.2016.03.017. [Epub ahead of print]. PubMed

Chubak J, Whitlock EP, Williams SB, Kamineni A, Burda BU, Buist DS, Anderson ML. Aspirin for the prevention of cancer incidence and mortality: systematic evidence reviews for the U.S. Preventive Services Task Force. Ann Intern Med. 2016 Apr 12. doi: 10.7326/M15-2117. [Epub ahead of print]. PubMed

Burnett-Hartman AN, Mehta SJ, Zheng Y, Ghai NR, McLerran DF, Chubak J, Quinn VP, Skinner CS, Corley DA, Inadomi JM, Doubeni CA. Racial/ethnic disparities in colorectal cancer screening across healthcare systems. Am J Prev Med. 2016 Apr 1. pii: S0749-3797(16)00105-7. doi: 10.1016/j.amepre.2016.02.025. [Epub ahead of print]. PubMed

Green BB, Anderson ML, Chubak J, Baldwin LM, Tuzzio L, Catz S, Cole A, Vernon SW. Colorectal cancer screening rates increased after exposure to the Patient-Centered Medical Home (PCMH). J Am Board Fam Med. 2016;29(2):191-200. doi: 10.3122/jabfm.2016.02.150290.  PubMed

Chubak J, Hubbard R. Defining and measuring adherence to cancer screening. J Med Screen. 2016 Mar 4. pii: 0969141316630766. [Epub ahead of print]. PubMed

Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, Stout NK, Tosteson AN, Henderson LM, Alford-Teaster JA, Onega TL. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. 2016 Feb 15;122(4):611-7. doi: 10.1002/cncr.29805. Epub 2015 Dec 28. PubMed

Shirts BH, Casadei S, Jacobson AL, Lee MK, Gulsuner S, Bennett RL, Miller M, Hall SA, Hampel H, Hisama FM, Naylor LV, Goetsch C, Leppig K, Tait JF, Scroggins SM, Turner EH, Livingston R, Salipante SJ, King MC, Walsh T, Pritchard CC. Improving performance of multigene panels for genomic analysis of cancer predisposition. Genet Med. 2016 Feb 4. doi: 10.1038/gim.2015.212. [Epub ahead of print]. PubMed

Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, Singal AG, Klabunde CN, Doubeni CA, Kamineni A, Levin TR, Schottinger JE, Green BB, Quinn VP, Rutter CM; PROSPR consortium. Time to colonoscopy after positive fecal blood test in four US healthcare systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):344-50. doi: 10.1158/1055-9965.EPI-15-0470.Cancer Epidemiol Biomarkers Prev. 2016 Feb 3. [Epub ahead of print]. PubMed

Rutter CM, Knudsen AB, Marsh TL, Doria-Rose VP, Johnson E, Pabiniak C, Kuntz KM, van Ballegooijen M, Zauber AG, Lansdorp-Vogelaar I. Validation of models used to inform colorectal cancer screening guidelines: accuracy and implications. Med Decis Making. 2016 Jul;36(5):604-14. doi: 10.1177/0272989X15622642. Epub 2016 Jan 8. PubMed